Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 1,653 across all filing types
Latest filing 2024-05-31 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
独立董事提名人声明与承诺(杜兰)
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment by the nominating party regarding the nomination of an independent director candidate for the company's board. It details qualifications, compliance with regulatory requirements, and declarations related to the nominee's independence and eligibility. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically about director nomination and compliance. The document length is 4409 characters, which is relatively short and does not contain financial data or report publication language. Therefore, it is best classified as Board/Management Information (MANG).
2024-05-31 Chinese
独立董事候选人声明与承诺(于李胜)
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement from an independent director candidate for Shenzhen BGI Genomics Co., Ltd. It outlines the candidate's qualifications, compliance with regulatory requirements, and commitments related to serving as an independent director. There is no financial data, no mention of financial results, no report publication, or voting results. The content is focused on board/management information specifically about a director candidate's qualifications and declarations. This fits the category of Board/Management Information (MANG). The document length is 4683 characters, which is sufficient for a detailed declaration rather than a brief announcement or certification.
2024-05-31 Chinese
第四届独立董事候选人关于参加独立董事培训并取得独立董事资格证书的承诺函(侯志波)
Board/Management Information Classification · 95% confidence The document is a commitment letter from an independent director candidate regarding participation in training and obtaining a qualification certificate. It relates to board/management matters, specifically about an independent director candidate's qualifications and compliance with regulatory requirements. It is not a financial report, audit, or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG). The document is short and formal, focusing on management qualifications rather than financial or regulatory filings.
2024-05-31 Chinese
独立董事提名人声明与承诺(于李胜)
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment by the nominating party regarding the nomination of an independent director candidate for the company's board. It details qualifications, compliance with regulatory requirements, and declarations related to the nominee's independence and eligibility. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically about director nomination and related compliance. Therefore, it fits the category of Board/Management Information (MANG). The document length is 4412 characters, which is sufficient for a detailed nomination statement but not a full report or announcement of a report publication.
2024-05-31 Chinese
第三届董事会第二十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Shenzhen BGI Genomics Co., Ltd. It details the convening of the third board's 26th meeting, election of the fourth board members, approval of remuneration plans, and scheduling of the next shareholders' meeting. The content focuses on board and management changes, election of directors, and related governance matters. There are no financial statements, audit opinions, or earnings data presented. The document is not a report but a meeting resolution announcement related to board composition and management. Therefore, it fits the category of Board/Management Information (MANG). The document length is 2521 characters, which is consistent with a meeting resolution announcement rather than a full report.
2024-05-31 Chinese
关于公司监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and nomination of members to the company's supervisory board (监事会换届选举). It details the nomination of candidates, their qualifications, and the process for election at the upcoming shareholders' meeting. There is no financial data, no discussion of financial results, no audit information, and no mention of report publication. The content focuses on changes in the supervisory board, which is part of the company's governance and management structure. Therefore, this document fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-05-31 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.